interferon
ifn
induc
capac
intact
ndv
virion
particl
sever
structur
compon
compar
use
human
pbml
ifn
produc
cell
intact
inactiv
virion
well
nucleocapsid
fraction
differ
significantli
ifninduc
capac
contrast
genom
rna
well
protein
fraction
envelop
induc
ifn
titr
level
achiev
virion
ndvinduc
ifn
product
could
block
specif
incub
polyclon
antindvmonoclon
antibodi
mab
two
three
antihnmab
antindvmab
direct
f
np
protein
addit
ifn
induct
fix
mdbk
cell
express
ndv
surfac
protein
infect
ndv
ulster
inhibit
one
two
antifmab
result
suggest
induct
ifn
synthesi
human
pbml
complex
process
involv
hn
protein
also
uncleav
f
protein
precursor
compon
protein
fraction
enter
cell
genom
rna
newcastl
diseas
viru
ndv
member
viru
famili
paramyxovirida
ndv
import
pathogen
poultri
caus
respiratori
central
nervou
symptom
potenti
high
mortal
rate
speci
ndv
compris
mani
strain
wide
rang
virul
molecular
basi
thereof
found
cleavabl
two
surfac
glycoprotein
hemagglutininneuraminidas
hn
especi
fusion
correspond
author
present
correspond
address
maxplanckinstitut
immunobiolog
sttibeweg
freiburg
phone
fax
f
protein
nagai
et
al
kawahara
et
al
latter
cleav
mani
cell
system
therebi
activ
velogen
mesogen
strain
lentogen
one
nagai
et
al
extrem
lentogen
strain
ndv
ulster
contain
glycoprotein
uncleav
form
millar
et
al
nagai
et
al
sato
et
al
third
envelop
protein
matrix
protein
locat
inner
side
lipid
membran
mediat
bind
nucleocapsid
area
cell
membran
contain
viral
surfac
glycoprotein
role
assembl
viru
function
known
protein
far
detect
nucleu
infect
cell
faaberg
peepl
peepl
et
al
protein
probabl
import
besid
role
pathogen
poultri
viru
well
known
excel
ifn
induc
eg
klein
et
al
featur
render
ndv
suitabl
model
viru
studi
mechan
ifn
induct
import
cytokin
group
especi
protect
viral
infect
tumor
diseas
mani
attempt
made
defin
mechan
ifn
induct
howev
intrins
ifn
induc
ndv
yet
identifi
studi
publish
far
part
indirectli
design
produc
conflict
result
meager
burk
well
lomniczi
discuss
hypothesi
subtl
activ
virionassoci
rnapolymeras
respons
ifn
induct
author
assum
primari
transcript
follow
format
doublestrand
ds
rna
necessari
ifn
induct
sheaff
et
al
genom
rna
intrins
induc
molecul
lomniczi
lymphoid
cell
shown
simpli
contact
cell
virion
surfac
suffici
induc
ifn
product
wherea
fibroblast
viru
enter
cell
ito
et
al
ito
hosaka
best
knowledg
one
descript
paramyxoviru
surfac
protein
ifn
induc
lymphoid
cell
ito
et
al
author
found
isol
sendai
viru
hn
protein
abl
stimul
releas
low
ifn
titr
supernat
mous
spleen
cell
report
show
hn
protein
also
ndv
compon
capabl
induc
ifn
releas
mononuclear
cell
three
ndv
strain
variou
degre
virul
use
ifn
induct
montana
velogen
la
sota
lentogen
ulster
extrem
lentogen
first
kindli
provid
dr
dirk
schneeganb
inst
f
poultri
diseas
munich
frg
third
prof
dr
volker
schimnach
dkfz
heidelberg
frg
von
hoegen
et
al
viru
propag
old
embryon
egg
purifi
allanto
fluid
sucros
gradient
centrifug
influenza
viru
parapoxviru
ovi
vaccin
strain
strain
use
control
mdbk
cell
trypsin
infect
ndv
ulster
multipl
infect
moi
held
suspens
h
cell
wash
twice
pb
fix
ice
paraformaldehyd
min
wash
twice
pb
remov
paraformaldehyd
express
ndv
surfac
protein
check
flow
cytometri
facscan
becton
dickinson
primari
antibodi
antihnmab
mous
antindvimmun
serum
secondari
antibodi
antimouseiggfitc
sigma
purifi
ndv
titr
egg
infecti
dose
ml
incub
bpl
trishcl
ph
min
min
magnet
stirrer
overnight
without
stir
inactiv
viru
batch
control
three
passag
embryon
egg
viral
envelop
protein
fraction
nucleocapsid
separ
method
scheid
choppin
modif
briefli
purifi
ndv
pellet
ultracentrifug
resuspend
sodiumphosph
ph
without
depend
whether
protein
detach
nucleocapsid
triton
sodiumdeoxychol
correspond
buffer
ad
ratio
amount
viru
protein
employ
h
incub
room
temperatur
uncleav
clump
viru
sediment
lowspe
centrifug
min
g
supernat
centrifug
h
g
order
pellet
nucleocapsid
resuspend
ten
buffer
mm
tri
ph
mm
edta
naci
deterg
remov
incub
bead
biorad
nucleocapsid
fraction
dialysi
method
volski
loyter
supernat
supernat
becam
turbid
format
reaggreg
envelop
collect
ultracentrifug
h
g
resuspend
ten
buffer
order
obtain
protein
fraction
ndv
cleav
triton
final
concentr
high
salt
buffer
sodiumphosph
ph
centrifug
step
supernat
dialys
low
salt
buffer
sodiumphosph
ph
insolubl
protein
could
sediment
g
min
isol
individu
envelop
protein
envelop
fraction
subject
immun
affin
chromatographi
mab
la
respect
coupl
sepharos
accord
manufactur
instruct
sampl
load
ca
mgfree
pb
column
wash
column
volum
buffer
protein
elut
trishcl
ph
chaotrop
agent
remov
ultrafiltr
amicon
cell
sm
filter
mwco
kda
sartoriu
liposom
prepar
loh
et
al
cholesterol
ladipalmitoylphosphatidylcholin
laphosphatidylethanolamin
sigma
molar
ratio
faaberg
peepl
immun
affinitypurifi
ndv
envelop
protein
ad
lipid
mixtur
everi
possibl
combin
genom
rna
ndv
isol
phenol
extract
sambrook
et
al
lipofectin
brl
use
introduc
genom
rna
peripher
blood
mononuclear
leukocyt
pbml
accord
manufactur
instruct
polyval
antindvantibodi
obtain
immun
rabbit
mice
two
time
purifi
ndv
la
sota
respect
week
interv
third
ndv
dose
appli
half
antigen
amount
first
time
freund
complet
adjuv
ad
antigen
wherea
viru
booster
mix
incomplet
freund
adjuv
anim
bled
three
week
last
booster
monoclon
antibodi
direct
ndv
gener
provid
liu
xiufan
xiulong
xiufan
weisong
xiufan
mab
tomoaki
kohama
umino
et
al
b
mab
yoshiyuki
nagai
nishikawa
et
al
mab
microtiterpl
nunc
coat
zg
purifi
viru
block
fc
tween
serial
twofold
dilut
antibodi
sampl
incub
h
peroxidaseconjug
antispeci
antibodi
sigma
adsorb
first
antibodi
min
reaction
step
follow
four
wash
tetramethylbenzidin
use
visual
antigenantibodyreact
od
measur
nm
multiscanphotomet
flow
laboratori
inhibit
hemagglutin
determin
describ
previous
mayr
et
al
human
pbml
separ
blood
suppli
sodiumcitr
ficollhypaqu
densiti
gradient
centrifug
bryum
cultur
suspens
x
cellsml
rpmi
fc
pbml
incub
sampl
virion
virion
compon
virion
antibodi
mixtur
latter
case
serial
dilut
respect
antibodi
incub
ndv
mo
h
room
temperatur
mixtur
ad
pbml
h
supernat
collect
uvirradi
min
inactiv
induc
viru
test
antivir
activ
ifn
content
supernat
determin
antivir
activ
mdb
k
cell
atcc
lytic
infect
vesicular
stomat
viru
cpe
inhibit
test
rubinstein
et
al
nih
rhulfn
ii
refer
prepar
catalogno
nihresearch
refer
reagent
note
includ
assay
antivir
activ
shown
ifn
effect
supernat
block
incub
antiifnserum
kindli
provid
prof
kari
cantel
nation
public
health
institut
helsinki
order
control
whether
ndv
eventu
inactiv
suffici
irradi
procedur
jacobsen
et
al
irradi
viru
sampl
test
protect
effect
ifn
assay
ndv
dose
tenfold
higher
use
induct
protocol
protect
cell
cell
lysi
except
ndv
strain
montana
caus
cpe
mdbk
cell
inactiv
complet
protein
type
ndv
fraction
determin
sdspage
laemmli
follow
silver
stain
gel
merril
et
al
western
blot
towbin
et
al
integr
genom
rna
control
agaros
gel
electrophoresi
sambrook
et
al
doseresponserelationship
ifn
induct
intact
ndv
bplinactiv
ndv
show
multipl
ndv
essenti
trigger
ifn
respons
human
pbml
titr
level
show
much
variat
tabl
titr
reach
maxim
level
viru
dose
moi
ifn
titr
order
magnitud
iuml
increas
viru
dose
result
higher
ifn
product
ifn
releas
drop
background
level
viru
dose
moi
virul
ndv
strain
influenc
ifn
induct
significantli
use
specif
block
protocol
attempt
determin
whether
surfac
structur
ndv
involv
ifn
induct
influenc
sever
polyand
monoclon
antindvantibodi
well
control
sera
mous
ascit
fluid
ifn
induct
ndv
test
polyclon
antindvantibodi
two
three
antihnantibodi
significantli
reduc
ifn
titr
reach
supernat
compar
mocktreat
virion
tabl
hand
mab
f
protein
inner
ndv
protein
influenc
ifn
releas
pbml
control
sera
ascit
fluid
analog
experi
done
control
virus
influenza
viru
parapoxviru
ovi
ppv
influenzaviru
chosen
hemagglutinin
contain
viru
effect
antihnmab
ifn
induct
ndv
ppv
includ
increas
ifn
induct
capac
incub
antippvantibodi
biittner
czerni
cp
per
comm
neither
antindvnor
antippvantibodi
control
serum
mous
ascit
fluid
reduc
ifn
induct
ppv
ovi
contrast
ifn
induct
influenza
viru
block
antindvantibodi
ndv
although
antindvantibodi
inhibit
ifn
induct
influenzaviru
antibodi
dilut
significantli
wherea
ifn
respons
stimul
ndv
impair
antibodi
dilut
influenc
antindvantibodi
ifn
induct
influenza
viru
parallel
crossreact
viru
antindvantibodi
elisa
hiassay
tabl
experi
describ
could
exclud
possibl
ifn
induct
block
antibodi
prevent
entri
viru
cell
therefor
correspond
approach
use
fix
mdbk
cell
express
ndv
ulster
surfac
glycoprotein
ratio
infect
mdbk
cell
pbml
latter
releas
ifn
titr
iu
ifnml
noninfect
fix
mdbk
cell
induc
ifn
respons
ifn
induct
reduc
undetect
level
antihnmab
contrast
result
virion
also
block
antifmab
la
tabl
antimmab
influenc
ifn
product
mdbk
cell
nt
cleav
ndv
ulster
glycoprotein
data
suggest
pbml
addit
hn
uncleav
f
protein
precursor
play
role
ifn
induct
subsequ
indirect
evid
ndv
surfac
structur
capabl
trigger
ifn
respons
differ
viru
compon
isol
tabl
fig
test
ifn
induc
capac
tabl
reaggreg
envelop
matrix
protein
fraction
first
hemagglutin
activ
infectiouswer
capabl
induc
ifn
although
titr
reach
achiev
stimul
protocol
virion
nonhemagglutin
infecti
nucleocapsid
fraction
induc
ifn
respons
level
intact
ndv
particl
electron
microscopi
nucleocapsid
fraction
show
activ
due
relev
contamin
intact
virion
tabl
ndv
envelop
protein
includ
protein
isol
immun
affin
chromatographi
isol
ndv
protein
abl
provok
detect
ifn
releas
also
case
incorpor
liposom
contrast
isol
ndv
rna
also
capabl
stimul
ifn
product
provid
introduc
pbml
lipofectin
ndv
genom
rna
lipofectin
alon
induc
measur
ifn
releas
lipofectin
enhanc
ifn
induct
ndv
paper
demonstr
pbml
cultur
infect
ndv
neither
virul
viral
replic
essenti
stimul
ifn
releas
contact
ifn
produc
cell
ifninduc
structur
suffici
one
ifn
induc
ndv
hn
protein
shown
sendai
viru
ito
hosaka
addit
found
particip
f
protein
precursor
probabl
protein
isol
genom
rna
ifn
induct
replic
inactiv
ndv
stimul
ifn
product
pbml
degre
irrespect
strain
differ
accord
result
obtain
anoth
ifn
stimul
protocol
use
mous
spleen
cell
ito
et
al
ito
hosaka
author
describ
mous
l
cell
howev
ndv
replic
cell
induc
ifn
synthesi
ito
et
al
suggest
differ
mechan
ifn
induct
exist
fibroblast
lymphoid
cell
bplinactiv
destroy
hemagglutin
activ
ndv
like
bplinactiv
ndv
capabl
enter
host
cell
therefor
rna
synthesi
alkyl
sequenc
formal
exclud
result
rna
polymeras
activ
ndv
genom
may
theoret
provid
enough
stimulu
start
ifnsynthesi
character
surfac
structur
involv
ifn
stimul
influenc
antindvimmun
sera
sever
differ
antindvmab
ifn
induct
determin
polyclon
antindvantibodi
two
three
antihnmab
block
ifn
product
neutral
mab
without
effect
ifn
induct
l
antifmab
weisong
xiufan
umino
et
al
ndv
glycoprotein
express
surfac
fix
cell
elut
infecti
viru
exclud
capabl
stimul
ifn
product
see
also
capobianchi
et
al
lebon
jestin
cherbonnel
charley
laud
induct
process
bound
entri
viru
cell
inhibitori
activ
antifmab
recogn
cleav
uncleav
f
protein
xiulong
xiufan
restrict
viru
contain
uncleav
f
protein
indic
epitop
f
protein
precursor
miss
matur
protein
play
role
ifn
induct
two
line
control
experi
demonstr
antibodymedi
inhibit
ifn
induct
specif
event
firstli
control
sera
ascit
fluid
show
inhibit
activ
secondli
antindvantibodi
exert
inhibitori
effect
ifn
stimul
mediat
poxviru
ppv
ovi
wherea
inhibit
ifn
product
induc
close
relat
orthomyxoviru
influenza
viru
latter
result
expect
inhibit
due
specif
antigen
antibodi
reaction
antindvantibodi
crossreact
influenza
viru
analyt
elisa
well
function
hi
assay
explain
antiinfluenza
viru
antibodi
influenc
ifn
induct
ndv
perhap
latter
recogn
epitop
necessari
hemagglutin
involv
ifn
induct
ifn
induct
protocol
isol
envelop
matrix
protein
nucleocapsid
fraction
reveal
ifn
induc
activ
unlik
singl
type
induc
molecul
contamin
differ
virion
fraction
properti
crucial
ifn
induct
vari
depend
individu
compon
test
effici
stimul
ifn
respons
envelop
protein
aggreg
complex
retain
hemagglutin
activ
contrast
matrix
protein
fraction
consist
mainli
aggreg
protein
hemagglutin
still
induc
ifn
context
interest
protein
found
nucleu
ndvinfect
cell
faaberg
peepl
isol
nucleocapsid
fraction
still
infecti
ifninduc
activ
nucleocapsid
fraction
independ
infect
nucleocapsid
isol
deoxycholatedisrupt
ndv
instead
treatment
triton
infecti
induc
ifn
envelop
protein
stain
immunoblot
deriv
empti
envelop
nucleocapsid
fraction
could
sole
sourc
ifninduc
compon
concentr
fraction
lower
minim
protein
amount
envelop
fraction
requir
measur
ifn
releas
besid
nucleocapsid
fraction
show
ha
activ
order
test
hn
f
protein
separ
protein
isol
immun
affin
chromatographi
none
alon
integr
liposom
either
combin
could
provok
measur
ifn
respons
possibl
explan
could
purif
procedur
destroy
ifninduc
activ
thu
direct
proof
ifn
induct
one
type
ndv
protein
could
obtain
hand
possibl
achiev
ifn
product
introduct
ndv
genom
rna
pbml
rna
ad
pbml
without
prior
incub
lipofectin
induc
ifn
either
degrad
reach
cell
abl
enter
necessarili
demonstr
releas
ifn
induc
rna
regular
ndv
genom
paramyxoviru
stock
report
contain
mixtur
minu
plu
strand
genom
portner
kingsburi
indic
rna
strand
differ
polar
form
dsrna
also
possibl
intramolecular
dsrna
format
exclud
dsrna
might
induc
ifn
furthermor
viral
protein
synthes
genom
cell
enzym
could
lead
ifn
synthesi
